Comparison of coronary heart disease genetic assessment with conventional cardiovascular risk assessment in primary care: reflections on a feasibility study
- 23 March 2015
- journal article
- research article
- Published by Cambridge University Press (CUP) in Primary Health Care Research & Development
- Vol. 16 (06), 607-617
- https://doi.org/10.1017/s1463423615000122
Abstract
AimThis study assesses the feasibility of collecting genetic samples and self-reported outcome measures after cardiovascular risk assessment, and presenting the genetic test results to participants.BackgroundCoronary heart disease (CHD) genetic tests are increasingly available through direct-to-consumer marketing, but their potential clinical impact on cardiovascular risk assessment is unclear.MethodsObservational study in 10 British general practices in Central England. A total of 320 individuals, who had completed conventional cardiovascular risk assessment, were offered CHD genetic test, with follow-up outcome questionnaire at eight months for lifestyle change and State-Trait Anxiety.FindingsA total of 119 (37%) participants returned genetic test specimens, with over a third reporting family history of CHD in a specified relative; 79 (66.4%) were categorized above-average risk on conventional cardiovascular risk assessment, 65 of whom (82.3%) were only average risk on genetic assessment. The dietary fat questionnaire was poorly completed while study participation was not associated with increased anxiety (mean increase in anxiety score=2.1; 95% CI −0.1–4.3;P=0.06).ConclusionAs a feasibility study, over a third of individuals offered genetic testing in primary care, as part of CVD risk assessment, took up the offer. Although intervention did not appear to increase anxiety, this needs further evaluation. To improve generalizability and effect size, future studies should actively engage individuals from wider socio-economic backgrounds who may not have already contemplated lifestyle change. The current research suggests general practitioners will face the clinical challenge of patients presenting with direct-to-consumer genetic results that are inconsistent with conventional cardiovascular risk assessment.Keywords
This publication has 29 references indexed in Scilit:
- Genetic Markers Enhance Coronary Risk Prediction in Men: The MORGAM Prospective CohortsPLOS ONE, 2012
- Heart Disease and Stroke Statistics—2012 UpdateCirculation, 2012
- Direct-to-consumer testing: more risks than opportunitiesInternational Journal of Clinical Practice, 2011
- Utility of genetic determinants of lipids and cardiovascular events in assessing riskNature Reviews Cardiology, 2011
- Effect of Direct-to-Consumer Genomewide Profiling to Assess Disease RiskThe New England Journal of Medicine, 2011
- Effects of communicating DNA-based disease risk estimates on risk-reducing behavioursEmergencias, 2010
- Coronary Heart Disease Risk Prediction in the Era of Genome-Wide Association StudiesCirculation, 2010
- Does genomic risk information motivate people to change their behavior?Genome Medicine, 2009
- Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controlsNature, 2007
- The development of a six‐item short‐form of the state scale of the Spielberger State—Trait Anxiety Inventory (STAI)British Journal of Clinical Psychology, 1992